Shunqing Wang - Concepedia

Author

Shunqing Wang

Also Known As

Chaofeng Liang, Fangyuan Zhang, Shun-Qing Wang, Shun-qing WANG, Shun-qing Wang, Shunqing Q. Wang, Shunqing Wang, WANG Shunqing, Wang Shunqing, Wang, Shun-Qing

203

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

Guangzhou Medical University Guangzhou First People's Hospital Peking University People's Hospital Peking University Southern Medical University

About

Shunqing Wang is an author at Guangzhou Medical University specializing in medicine, hematology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	15	17	529
2	Health Sciences	5	5	113
3	Engineering	1	1	20
4	Natural Sciences	1	1	85
5	Public Health	1	1	41

Shunqing Wang

Publications

2.4K

Citations

H-Index

Page 1

	Year	Citations
Upfront haploidentical transplant for acquired severe aplastic anemia: registry-based comparison with matched related transplant Lan‐Ping Xu, Song Jin, Shunqing Wang, Journal of Hematology & Oncology	2017	195
Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth Ningning Liu, Xiaofen Li, Hongbiao Huang, Oncotarget	2014	169
Gambogic Acid Induces Apoptosis in Imatinib-Resistant Chronic Myeloid Leukemia Cells via Inducing Proteasome Inhibition and Caspase-Dependent Bcr-Abl Downregulation Xianping Shi, Xin Chen, Xiaofen Li, Clinical Cancer Research	2013	129
Molecular Mechanism of the Bifunctional Role of Lipopolysaccharide in Osteoclastogenesis Jianzhong Liu, Shunqing Wang, Ping Zhang, Journal of Biological Chemistry	2009	120
Antithymocyte Globulin for Matched Sibling Donor Transplantation in Patients With Hematologic Malignancies: A Multicenter, Open-Label, Randomized Controlled Study Ying‐Jun Chang, Depei Wu, Yongrong Lai, Journal of Clinical Oncology	2020	120
microRNA‐130a suppresses breast cancer cell migration and invasion by targeting FOSL1 and upregulating ZO‐1 Xiaowei Chen, Min Zhao, Jin Huang, Journal of Cellular Biochemistry	2018	100
Gambogic Acid Is a Tissue-Specific Proteasome Inhibitor In Vitro and In Vivo Xiaofen Li, Shouting Liu, Hongbiao Huang, Cell Reports ProteasomeGliomaTumor BiologyAnti-cancer AgentProteomics	2012	85
Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial Ke Zhao, Ren Lin, Zhiping Fan, Journal of Hematology & Oncology	2022	84
A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases Ningning Liu, Chunjiao Liu, Xiaofen Li, Scientific Reports	2014	75
Knowledge, Attitudes, and Practices on Malaria Prevention Among Chinese International Travelers Min Zhang, Zhiyong Liu, Hongtao He, Journal of Travel Medicine	2011	66

Page 1